411 related articles for article (PubMed ID: 33017914)
1. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.
Cure E; Cumhur Cure M
Med Hypotheses; 2020 Oct; 143():110185. PubMed ID: 33017914
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.
Ragia G; Manolopoulos VG
Eur J Clin Pharmacol; 2020 Dec; 76(12):1623-1630. PubMed ID: 32696234
[TBL] [Abstract][Full Text] [Related]
3. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
Rochette L; Ghibu S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
[TBL] [Abstract][Full Text] [Related]
4. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
Xiao L; Sakagami H; Miwa N
Viruses; 2020 Apr; 12(5):. PubMed ID: 32354022
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.
Cure E; Cumhur Cure M
Diabetes Metab Syndr; 2020; 14(4):349-350. PubMed ID: 32311651
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
Milne S; Yang CX; Timens W; Bossé Y; Sin DD
Lancet Respir Med; 2020 Jun; 8(6):e50-e51. PubMed ID: 32411576
[No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
10. Relative Limited Impact of COVID-19 on Diabetes: A Personal View.
de Galan BE
J Diabetes Sci Technol; 2020 Jul; 14(4):727-728. PubMed ID: 32468834
[No Abstract] [Full Text] [Related]
11. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
12. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
14. Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine.
Bonaccorsi G; Gambacciani M; Gemmati D
Minerva Ginecol; 2020 Jun; 72(3):178-179. PubMed ID: 33000616
[No Abstract] [Full Text] [Related]
15. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
Sawalha AH; Zhao M; Coit P; Lu Q
Clin Immunol; 2020 Jun; 215():108410. PubMed ID: 32276140
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.
Afsar B; Kanbay M; Afsar RE
Med Hypotheses; 2020 Oct; 143():109857. PubMed ID: 32464493
[No Abstract] [Full Text] [Related]
17. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions.
Kruglikov IL; Shah M; Scherer PE
Elife; 2020 Sep; 9():. PubMed ID: 32930095
[TBL] [Abstract][Full Text] [Related]
18. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
Li SR; Tang ZJ; Li ZH; Liu X
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1021-1026. PubMed ID: 32285293
[TBL] [Abstract][Full Text] [Related]
19. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
[TBL] [Abstract][Full Text] [Related]
20. Possible protective role of contact Lens against SARS COV 2.
Plotas P; Kagkelaris K; Konstantopoulou A; Makri O; Georgakopoulos CD
J Fr Ophtalmol; 2020 Sep; 43(7):e233-e234. PubMed ID: 32564981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
